Literature DB >> 2279721

Plasma versus bone marrow desipramine: a comparative study.

C L Winek1, S E Westwood, W W Wahba.   

Abstract

Correlation between plasma and bone marrow tricyclic antidepressants has not been studied before. Two groups of rabbits were given 10 and 20 mg of desipramine/kg body weight, respectively. Desipramine was administered to the animals once daily by mouth for 5 days. On the fifth day the animals were sacrificed and blood and bone marrow samples were collected and analyzed using a high performance liquid chromatographic (HPLC) method. Data showed that a correlation exists between bone marrow and blood desipramine. The bone marrow desipramine concentration increased as its blood levels increased. The average ratio of bone marrow to blood desipramine +/- S.D. (standard deviation) in both dosage groups was 37.2 +/- 4.46 with a range of 30.99-44.82. This investigation is promising and shows that bone marrow could be used as an alternative tissue in the absence of a suitable blood sample.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2279721     DOI: 10.1016/0379-0738(90)90271-y

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  3 in total

Review 1.  State-of-the-art of bone marrow analysis in forensic toxicology: a review.

Authors:  Nathalie Cartiser; Fabien Bévalot; Laurent Fanton; Yvan Gaillard; Jérôme Guitton
Journal:  Int J Legal Med       Date:  2011-03       Impact factor: 2.686

2.  Using bone marrow matrix to analyze meprobamate for forensic toxicological purposes.

Authors:  F Bévalot; M P Gustin; N Cartiser; Y Gaillard; C Le Meur; L Fanton; J Guitton; D Malicier
Journal:  Int J Legal Med       Date:  2013-02-12       Impact factor: 2.686

3.  Postmortem Analysis of Opioids and Metabolites in Skeletal Tissue.

Authors:  Michiel Vandenbosch; Stane Pajk; Wouter Van Den Bogaert; Joke Wuestenbergs; Wim Van de Voorde; Eva Cuypers
Journal:  J Anal Toxicol       Date:  2022-08-13       Impact factor: 3.220

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.